Skip to content

Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction

A Prospective, Multicenter, Open Label Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction Assessed by GoEyes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05049070
Enrollment
349
Registered
2021-09-17
Start date
2021-09-15
Completion date
2023-06-30
Last updated
2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Keywords

Refractive Errors, Myopia, Mobile Applications

Brief summary

This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as compared to standard of care subjective manifest refraction performed by a health care provider, in subjects who have no known ocular disease or condition other than refractive error.

Detailed description

GoEyes is a Mobile Medical Application, which can be downloaded to a smartphone and is being developed as a self -administered subjective refraction examination that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals. The Study will be conducted in 2 parts; Part 1 and Part 2. Approximately 59 participants will be enrolled In Part 1. Part 1 participants will have a GoEyes refraction test in clinic on two separate days and will also have a standard of care refraction test performed by a health care provider and best corrected visual acuity assessments. Approximately 349 participants will be enrolled in Part 2. Part 2 participants will self administer the GoEyes test at home on 2 separate days and will also have in clinic standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.

Interventions

DIAGNOSTIC_TESTMobile medical application to self administer a subjective refraction test

GoEyes is a software as a medical device and mobile medical application, which is downloaded to a smartphone and is a self-administered subjective refraction test that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals

DIAGNOSTIC_TESTStandard of care refraction test

Standard of care subjective manifest refraction test performed by a healthcare professional

Sponsors

1800 Contacts, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The Best Corrected Visual Acuity (BCVA) assessor will be masked to GoEyes and Standard of Care refraction results.

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. Males or females aged 18-39 years who currently wear glasses and/or soft contact lenses to correct refractive error 2. Normal color vision 3. Able to use both hands at the same time and to hear, understand and verbally respond to audio instructions 4. Have single vision lenses only 5. Able to provide informed consent -

Exclusion criteria

1. Have any ongoing disease or ocular condition other than refractive error 2. Have a history of permanent vison loss 3. Have a neurological condition affecting vision 4. Have worn glasses since age 6 or younger 5. Have a prism in their prescription 6. Use Rigid gas permeable lenses or OrthoK lenses 7. Have had laser refractive surgery or any other eye surgery 8. Use prescription eye drops -

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Adverse Events in Part 28 Days
90% Concordance for sphere power and cylinder power (monocular)Baseline
Descriptive statistics for concordance of cylinder axis (monocular) stratified by cylinder powerBaseline
Monocular refractive outcomesBaselineLower confidence limit of ≥ 90% for concordance (for right and left eyes separately)
Monocular visual acuityBaselineLower confidence limit of ≥95% (for right and left eyes combined)
Proportion of out-of-range eye that are correctly excludedBaseline
Incidence of Adverse Events in Part 121 days

Secondary

MeasureTime frame
Descriptive statistics for sphere power and cylinder power (monocular)Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)
Descriptive statistics for cylinder axis (monocular) stratified by cylinder powerBaseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)
Descriptive statistics for concordance of monocular refractive outcomes (for right and left eyes separatelyBaseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)
Descriptive statistics for monocular and binocular visual acuity (for right and left eyes combinedBaseline
Proportion of out of range eyes that are correctly excludedBaseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)
Comparison of test and re-test measurements to Standard of Care (SOC) dataBaseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)
Rate of disagreement between GoEyes screening at home and in-clinic screeningBaseline

Countries

United States

Contacts

Primary ContactKaren Howse
khowse@luna.io

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026